ArticleAnimal models and experimental medicine2026
Evaluation of therapeutic effects of D-limonene following orchiopexy in the rat model of cryptorchidism.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCryptorchidism impairs spermatogenesis, causes infertility, and increases malignancy risk. Orchiopexy, the standard treatment, often fails to fully restore testicular function. This study evaluated the adjunctive effects of D-limonene in prepubertal rats with bilateral cryptorchidism.
methodsTwenty-four male rats were allocated into four groups: sham-operated (SH), cryptorchid control with orchiopexy (CT), and two orchiopexy groups receiving low-dose (50 mg/kg, Lim-50) or high-dose (100 mg/kg, Lim-100) D-limonene. Assessments included oxidative stress markers in testicular tissue (total antioxidant capacity [TAC], malondialdehyde [MDA], superoxide dismutase [SOD], and glutathione peroxidase [GPx]), macroscopic indices (testicular index [TI], absolute testicular weight [TW], and testicular weight index [TWI]), histopathological parameters (Johnsen score [JS], epithelial height [EHS], and seminiferous tubule diameter [STD]), apoptosis-related proteins (Bax, Bcl-2, Caspase-3, and TNF-α), serum testosterone, and sperm parameters.
resultsD-limonene improved several indices of testicular injury following orchiopexy in cryptorchid rats. Both treatment doses increased TAC, while the higher dose more effectively reduced MDA and improved SOD activity. Testicular morphometric and histopathological parameters, including TW, TI, TWI, JS, EHS, and STD, were significantly improved. D-Limonene also decreased pro-apoptotic markers (Bax and Cleaved Caspase-3), increased anti-apoptotic markers (Bcl-2 and Pro-Caspase-3), reduced TNF-α expression and apoptotic cell counts, and enhanced serum testosterone and sperm quality. However, full normalization of all parameters was not achieved.
conclusionAdjunctive D-limonene administration following orchiopexy attenuated oxidative stress, inflammation, and apoptosis, and partially restored testicular structure and function in experimental cryptorchidism. These findings support D-limonene as a promising supplementary strategy with partial but meaningful protective effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.